Many studies in different tumour types have investigated ezrin expression to determine if it has prognostic value, with meta‐analyses demonstrating that ezrin may be applicable as a prognostic marker in cancer patients with solid tumours; despite results from certain papers providing controversial results.6 The gene discussed is EZR; the disease is cancer.